Supplement of a bile acid mixture (taurocholic, glycocholic, deoxycholic, and cholic acid) exhibited an anti-obesity effect via the activation of hypothalamic TGR5 (Castellanos-Jankiewicz et al., 2021). The gene discussed is GPBAR1; the disease is obesity due to melanocortin 4 receptor deficiency.